Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Large-scale testing (Phase 3)Study completedNCT00112996
What this trial is testing

Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Who this might be right for
NeurotoxicityUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 244
Large-scale testing (Phase 3)Looking for participantsNCT05624138
What this trial is testing

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

Who this might be right for
Neuropathy;Peripheral
Tanta University 64
Post-approval studies (Phase 4)Study completedNCT05510856
What this trial is testing

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Who this might be right for
Oncology
Tanta University 93
Not applicableLooking for participantsNCT07427537
What this trial is testing

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

Who this might be right for
Cancer, LungColon NeoplasmNeuropathy;Peripheral
University Hospital, Clermont-Ferrand 90
Not applicableStudy completedNCT07409987
What this trial is testing

TENS and Compression for Established Oxaliplatin-Induced Peripheral Neuropathy

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral NeuropathyGastrointestinal Cancers
Cumhuriyet University 140
Very early researchLooking for participantsNCT07167446
What this trial is testing

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Who this might be right for
Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsMetastatic Colorectal Cancer (CRC)Peripheral Neuropathy Due to Chemotherapy
Fox Chase Cancer Center 30
Not applicableNot Yet RecruitingNCT07511569
What this trial is testing

Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Who this might be right for
Chemotherapy Induced Neuropathic PainNeuropathy ToxicTaxane-induced Peripheral Neuropathy+1 more
Centre Hospitalier de Bligny 192
Not applicableStudy completedNCT06844409
What this trial is testing

Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
P. Herzen Moscow Oncology Research Institute 54
Not applicableStudy completedNCT07391163
What this trial is testing

Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Tanta University 46
Early research (Phase 1)Looking for participantsNCT06856447
What this trial is testing

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
toqa saad mohammed mohammed 22
Large-scale testing (Phase 3)Ended earlyNCT00603577
What this trial is testing

Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens

Who this might be right for
Colorectal Neoplasms
Sanofi 102